Sigma Planning Corp’s Rein Therapeutics RNTX Stock Holding History

Sigma Planning Corp’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$287K	Buy	357,477 +3,800	+1%	+$3.12K	0.01%	1082
2026 Q2	$368K	Buy	353,677 +5,000	+1%	+$6.05K	0.01%	1047
2026 Q1	$453K	Buy	348,677 +101,400	+41%	+$126K	0.01%	877
2025 Q4	$299K	Sell	247,277 -6,550	-3%	-$9.03K	0.01%	1027
2025 Q3	$291K	Sell	253,827 -22,950	-8%	-$29.1K	0.01%	1042
2025 Q2	$387K	Sell	276,777 -28,398	-9%	-$51.1K	0.01%	882
2025 Q1	$540K	Buy	305,175 +68,965	+29%	+$145K	0.02%	701
2024 Q4	$543K	Buy	236,210 +23,800	+11%	+$72.1K	0.02%	711
2024 Q3	$752K	Buy	212,410 +86,185	+68%	+$230K	0.02%	592
2024 Q2	$350K	Buy	126,225 +58,240	+86%	+$239K	0.01%	860
2024 Q1	$451K	Buy	67,985 +51,405	+310%	+$246K	0.01%	801
2023 Q4	$50.5K	Buy	+16,580	New	+$32.3K	﹤0.01%	829

Other funds holding RNTX

Americana Partners Houston, Texas $4.67B AUM 26.97% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Gleason Group Prospect, Kentucky $1.13B AUM 12.68% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Cane Capital Partners Saint Francisville, Louisiana $269M AUM 28.65% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Sigma Planning Corp's RNTX Position: Q3 2026 in Review

Sigma Planning Corp increased its Rein Therapeutics (RNTX) stake by 1.1% in Q3 2026, buying an estimated $3.12K and bringing the position to 357,477 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #1082.

Sigma Planning Corp first reported a position in RNTX in Q4 2023 and has held it in 12 quarters since. The position peaked at $752K in Q3 2024. 12 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.

Sigma Planning Corp held 357,477 shares of Rein Therapeutics worth $287K as of Q3 2026.
Sigma Planning Corp bought 3,800 Rein Therapeutics shares in Q3 2026, an estimated $3.12K.
Rein Therapeutics made up 0.01% of Sigma Planning Corp's portfolio in Q3 2026, its #1082 holding.
Sigma Planning Corp first reported a position in Rein Therapeutics in Q4 2023 and has held it in 12 quarters since.
Sigma Planning Corp's Rein Therapeutics position peaked at $752K in Q3 2024.
12 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.